Potassium channel genes and benign familial neonatal epilepsy

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 17-53

  Maljevic, Snezana ^a   Lerche, Holger ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Developmental expression; Dominant negative effect; Haploinsufficiency; Heterologous expression; KCNQ2; KCNQ3; M current; Retigabine

Indexed keywords

ANKYRIN; ANKYRIN G; ANTICONVULSIVE AGENT; CAM PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; POTASSIUM CHANNEL KV1.1; PROTEIN; PROTEIN KINASE C; RETIGABINE; SHAL POTASSIUM CHANNEL; SYNTAXIN 1A; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ALLELE; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BENIGN CHILDHOOD EPILEPSY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CHROMOSOME 11P; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DNA LIBRARY; DYSKINESIA; ELECTROENCEPHALOGRAM; GENE EXPRESSION SYSTEM; GENE MUTATION; GENE THERAPY; GENOTYPE PHENOTYPE CORRELATION; HAPLOINSUFFICIENCY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANTILE SPASM; INTELLECTUAL IMPAIRMENT; JERVELL AND LANGE-NIELSEN SYNDROME; LENNOX GASTAUT SYNDROME; LONG QT SYNDROME; MEMBRANE DEPOLARIZATION; MEMBRANE STEADY POTENTIAL; MENTAL DEFICIENCY; MOTONEURON; MYOKYMIA; NERVE CONDUCTION; NERVE ENDING; NERVE EXCITABILITY; NERVE FIBER; NONHUMAN; OUTER HAIR CELL; PATHOPHYSIOLOGY; PENETRANCE; PHENOTYPE; PLURIPOTENT STEM CELL; POTASSIUM CHANNELOPATHY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PSYCHOMOTOR DEVELOPMENT; PYRAMIDAL NERVE CELL; REPOLARIZATION; RNA SPLICING; ROLANDIC EPILEPSY; SYMPATHETIC NERVE CELL; GENETICS; MUTATION;

EPILEPSY, BENIGN NEONATAL; HUMANS; MUTATION; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 84926318481     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00002-8     Document Type: Chapter

References (163)

1. Alaimo A., Gomez-Posada J.C., Aivar P., Etxeberria A., Rodriguez-Alfaro J.A., Areso P., Villarroel A. Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum. J. Biol. Chem. 2009, 284:20668-20675.
2. Alfonso I., Hahn J.S., Papazian O., Martinez Y.L., Reyes M.A., Aicardi J. Bilateral tonic-clonic epileptic seizures in non-benign familial neonatal convulsions. Pediatr. Neurol. 1997, 16:249-251.
3. Arrighi I., Bloch-Faure M., Grahammer F., Bleich M., Warth R., Mengual R., Drici M.D., Barhanin J., Meneton P. Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:8792-8797.
4. Bal M., Zhang J., Hernandez C.C., Zaika O., Shapiro M.S. Ca2+/calmodulin disrupts AKAP79/150 interactions with KCNQ (M-Type) K+ channels. J. Neurosci. 2010, 30:2311-2323.
5. Baloh R.W. Episodic ataxias 1 and 2. Handb. Clin. Neurol. 2012, 103:595-602.
6. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384:78-80.
7. Bassi M.T., Balottin U., Panzeri C., Piccinelli P., Castaldo P., Barrese V., Soldovieri M.V., Miceli F., Colombo M., Bresolin N., et al. Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC). Neurogenetics 2005, 6:185-193.
8. Battefeld A., Tran B.T., Gavrilis J., Cooper E.C., Kole M.H. Heteromeric kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons. J. Neurosci. 2014, 34:3719-3732.
9. Bean B.P. The action potential in mammalian central neurons. Nat. Rev. Neurosci. 2007, 8:451-465.
10. Bentley J.N., Chestek C., Stacey W.C., Patil P.G. Optogenetics in epilepsy. Neurosurg. Focus. 2013, 34:E4.
11. Bernard C., Anderson A., Becker A., Poolos N.P., Beck H., Johnston D. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 2004, 305:532-535.
12. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279:403-406.
13. Borgatti R., Zucca C., Cavallini A., Ferrario M., Panzeri C., Castaldo P., Soldovieri M.V., Baschirotto C., Bresolin N., Dalla Bernardina B., et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology 2004, 63:57-65.
14. Brodie M.J., Lerche H., Gil-Nagel A., Elger C., Hall S., Shin P., Nohria V., Mansbach H., Group R.S. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology 2010, 75:1817-1824.
15. Brown D.A., Adams P.R. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature 1980, 283:673-676.
16. Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R., Smith E.A., Kramer P., Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 1994, 8:136-140.
17. Castaldo P., del Giudice E.M., Coppola G., Pascotto A., Annunziato L., Taglialatela M. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J. Neurosci. 2002, 22:RC199.
18. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 1998, 18:53-55.
19. Coetzee W.A., Amarillo Y., Chiu J., Chow A., Lau D., McCormack T., Moreno H., Nadal M.S., Ozaita A., Pountney D., et al. Molecular diversity of K+ channels. Ann. N.Y. Acad. Sci. 1999, 868:233-285.
20. Cooper E.C., Aldape K.D., Abosch A., Barbaro N.M., Berger M.S., Peacock W.S., Jan Y.N., Jan L.Y. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4914-4919.
21. Cooper E.C., Harrington E., Jan Y.N., Jan L.Y. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J. Neurosci. 2001, 21:9529-9540.
22. Coppola G., Castaldo P., Miraglia del Giudice E., Bellini G., Galasso F., Soldovieri M.V., Anzalone L., Sferro C., Annunziato L., Pascotto A., et al. A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology 2003, 61:131-134.
23. Dedek K., Kunath B., Kananura C., Reuner U., Jentsch T.J., Steinlein O.K. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12272-12277.
24. Dedek K., Fusco L., Teloy N., Steinlein O.K. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res. 2003, 54:21-27.
25. Delmas P., Brown D.A. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat. Rev. Neurosci. 2005, 6:850-862.
26. Devaux J.J., Kleopa K.A., Cooper E.C., Scherer S.S. KCNQ2 is a nodal K+ channel. J. Neurosci. 2004, 24:1236-1244.
27. Doyle D.A., Morais Cabral J., Pfuetzner R.A., Kuo A., Gulbis J.M., Cohen S.L., Chait B.T., MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 1998, 280:69-77.
28. Du W., Bautista J.F., Yang H., Diez-Sampedro A., You S.A., Wang L., Kotagal P., Luders H.O., Shi J., Cui J., et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat. Genet. 2005, 37:733-738.
29. Etxeberria A., Santana-Castro I., Regalado M.P., Aivar P., Villarroel A. Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation. J. Neurosci. 2004, 24:9146-9152.
30. Etxeberria A., Aivar P., Rodriguez-Alfaro J.A., Alaimo A., Villace P., Gomez-Posada J.C., Areso P., Villarroel A. Calmodulin regulates the trafficking of KCNQ2 potassium channels. FASEB J. 2008, 22:1135-1143.
31. Etzioni A., Siloni S., Chikvashvilli D., Strulovich R., Sachyani D., Regev N., Greitzer-Antes D., Hirsch J.A., Lotan I. Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A. J. Neurosci. 2011, 31:14158-14171.
32. Faiz M., Nagy A. Induced pluripotent stem cells and disorders of the nervous system: progress, problems, and prospects. Neuroscientist 2013, 19:567-577.
33. Fister P., Soltirovska-Salamon A., Debeljak M., Paro-Panjan D. Benign familial neonatal convulsions caused by mutation in KCNQ3, exon 6: a European case. Eur. J. Paediatr. Neurol. 2013, 17:308-310.
34. French J.A., Abou-Khalil B.W., Leroy R.F., Yacubian E.M., Shin P., Hall S., Mansbach H., Nohria V., Investigators R.S. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology 2011, 76:1555-1563.
35. Garrido J.J., Giraud P., Carlier E., Fernandes F., Moussif A., Fache M.P., Debanne D., Dargent B. A targeting motif involved in sodium channel clustering at the axonal initial segment. Science 2003, 300:2091-2094.
36. Geiger J., Weber Y.G., Landwehrmeyer B., Sommer C., Lerche H. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain. Neurosci. Lett. 2006, 400:101-104.
37. Gilling M., Rasmussen H.B., Calloe K., Sequeira A.F., Baretto M., Oliveira G., Almeida J., Lauritsen M.B., Ullmann R., Boonen S.E., et al. Dysfunction of the heteromeric KV7.3/KV7.5 potassium channel is associated with autism spectrum disorders. Front. Genet. 2013, 4:54.
38. Goldman A.M., Glasscock E., Yoo J., Chen T.T., Klassen T.L., Noebels J.L. Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci. Transl. Med. 2009, 1:2ra6.
39. Gomez-Posada J.C., Etxeberria A., Roura-Ferrer M., Areso P., Masin M., Murrell-Lagnado R.D., Villarroel A. A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression. J. Neurosci. 2010, 30:9316-9323.
40. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 2005, 57:473-508.
41. Hadley J.K., Passmore G.M., Tatulian L., Al-Qatari M., Ye F., Wickenden A.D., Brown D.A. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium. J. Neurosci. 2003, 23:5012-5019.
42. Hahn A., Neubauer B.A. Sodium and potassium channel dysfunctions in rare and common idiopathic epilepsy syndromes. Brain Dev. 2009, 31:515-520.
43. Haitin Y., Attali B. The C-terminus of Kv7 channels: a multifunctional module. J. Physiol. 2008, 586:1803-1810.
44. Hart I.K., Maddison P., Newsom-Davis J., Vincent A., Mills K.R. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002, 125:1887-1895.
45. Hayashi T., Wakao S., Kitada M., Ose T., Watabe H., Kuroda Y., Mitsunaga K., Matsuse D., Shigemoto T., Ito A., et al. Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques. J. Clin. Invest. 2013, 123:272-284.
46. Heeroma J.H., Henneberger C., Rajakulendran S., Hanna M.G., Schorge S., Kullmann D.M. Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release. Dis. Model Mech. 2009, 2:612-619.
47. Hernandez C.C., Zaika O., Tolstykh G.P., Shapiro M.S. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J. Physiol. 2008, 586:1811-1821.
48. Heron S.E., Cox K., Grinton B.E., Zuberi S.M., Kivity S., Afawi Z., Straussberg R., Berkovic S.F., Scheffer I.E., Mulley J.C. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J. Med. Genet. 2007, 44:791-796.
49. Hibino H., Inanobe A., Furutani K., Murakami S., Findlay I., Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol. Rev. 2010, 90:291-366.
50. Higurashi N., Uchida T., Lossin C., Misumi Y., Okada Y., Akamatsu W., Imaizumi Y., Zhang B., Nabeshima K., Mori M.X., et al. A human Dravet syndrome model from patient induced pluripotent stem cells. Mol. Brain 2013, 6:19.
51. Hirose S., Zenri F., Akiyoshi H., Fukuma G., Iwata H., Inoue T., Yonetani M., Tsutsumi M., Muranaka H., Kurokawa T., et al. A novel mutation of KCNQ3 (c.925T->C) in a Japanese family with benign familial neonatal convulsions. Ann. Neurol. 2000, 47:822-826.
52. Hoshi N., Zhang J.S., Omaki M., Takeuchi T., Yokoyama S., Wanaverbecq N., Langeberg L.K., Yoneda Y., Scott J.D., Brown D.A., et al. AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists. Nat. Neurosci. 2003, 6:564-571.
53. Howard R.J., Clark K.A., Holton J.M., Minor D.L. Structural insight into KCNQ (Kv7) channel assembly and channelopathy. Neuron 2007, 53:663-675.
54. Hu H., Vervaeke K., Storm J.F. M-channels (Kv7/KCNQ channels) that regulate synaptic integration, excitability, and spike pattern of CA1 pyramidal cells are located in the perisomatic region. J. Neurosci. 2007, 27:1853-1867.
55. Hu W., Tian C., Li T., Yang M., Hou H., Shu Y. Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation. Nat. Neurosci. 2009, 12:996-1002.
56. Hunter J., Maljevic S., Shankar A., Siegel A., Weissman B., Holt P., Olson L., Lerche H., Escayg A. Subthreshold changes of voltage-dependent activation of the K(V)7.2 channel in neonatal epilepsy. Neurobiol. Dis. 2006, 24:194-201.
57. Jegla T.J., Zmasek C.M., Batalov S., Nayak S.K. Evolution of the human ion channel set. Comb. Chem. High Throughput Screen. 2009, 12:2-23.
58. Jensen C.S., Rasmussen H.B., Misonou H. Neuronal trafficking of voltage-gated potassium channels. Mol. Cell. Neurosci. 2011, 48:288-297.
59. Jentsch T.J. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci. 2000, 1:21-30.
60. Jespersen T., Grunnet M., Olesen S.P. The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda) 2005, 20:408-416.
61. Jiang Y., Lee A., Chen J., Cadene M., Chait B.T., MacKinnon R. The open pore conformation of potassium channels. Nature 2002, 417:523-526.
62. Jiao J., Yang Y., Shi Y., Chen J., Gao R., Fan Y., Yao H., Liao W., Sun X.F., Gao S. Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons. Hum. Mol. Genet. 2013, 22:4241-4252.
63. Kananura C., Biervert C., Hechenberger M., Engels H., Steinlein O.K. The new voltage gated potassium channel KCNQ5 and neonatal convulsions. Neuroreport 2000, 11:2063-2067.
64. Kaplan R.E., Lacey D.J. Benign familial neonatal-infantile seizures. Am. J. Med. Genet. 1983, 16:595-599.
65. Kharkovets T., Hardelin J.P., Safieddine S., Schweizer M., El-Amraoui A., Petit C., Jentsch T.J. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4333-4338.
66. Kharkovets T., Dedek K., Maier H., Schweizer M., Khimich D., Nouvian R., Vardanyan V., Leuwer R., Moser T., Jentsch T.J. Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness. EMBO J. 2006, 25:642-652.
67. Kubisch C., Schroeder B.C., Friedrich T., Lutjohann B., El-Amraoui A., Marlin S., Petit C., Jentsch T.J. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999, 96:437-446.
68. Kwan P., Schachter S.C., Brodie M.J. Drug-resistant epilepsy. N. Engl. J. Med. 2011, 365:919-926.
69. Lange W., Geissendorfer J., Schenzer A., Grotzinger J., Seebohm G., Friedrich T., Schwake M. Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels. Mol. Pharmacol. 2009, 75:272-280.
70. Large C.H., Sokal D.M., Nehlig A., Gunthorpe M.J., Sankar R., Crean C.S., Vanlandingham K.E., White H.S. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use. Epilepsia 2012, 53:425-436.
71. Lehmann-Horn F., Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol. Rev. 1999, 79:1317-1372.
72. Lemaillet G., Walker B., Lambert S. Identification of a conserved ankyrin-binding motif in the family of sodium channel alpha subunits. J. Biol. Chem. 2003, 278:27333-27339.
73. Lerche H., Biervert C., Alekov A.K., Schleithoff L., Lindner M., Klinger W., Bretschneider F., Mitrovic N., Jurkat-Rott K., Bode H., et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann. Neurol. 1999, 46:305-312.
74. Lerche C., Scherer C.R., Seebohm G., Derst C., Wei A.D., Busch A.E., Steinmeyer K. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J. Biol. Chem. 2000, 275:22395-22400.
75. Lerche H., Weber Y.G., Jurkat-Rott K., Lehmann-Horn F. Ion channel defects in idiopathic epilepsies. Curr. Pharm. Des. 2005, 11:2737-2752.
76. Li Y., Gamper N., Hilgemann D.W., Shapiro M.S. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 2005, 25:9825-9835.
77. Liao Y., Deprez L., Maljevic S., Pitsch J., Claes L., Hristova D., Jordanova A., Ala-Mello S., Bellan-Koch A., Blazevic D., et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain 2010, 133:1403-1414.
78. Liu Y., Lopez-Santiago L.F., Yuan Y., Jones J.M., Zhang H., O'Malley H.A., Patino G.A., O'Brien J.E., Rusconi R., Gupta A., et al. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism. Ann. Neurol. 2013, 74:128-139.
79. Long S.B., Campbell E.B., Mackinnon R. Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 2005, 309:897-903.
80. Maljevic S., Lerche C., Seebohm G., Alekov A.K., Busch A.E., Lerche H. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels. J. Physiol. 2003, 548:353-360.
81. Maljevic S., Wuttke T.V., Lerche H. Nervous system KV7 disorders: breakdown of a subthreshold brake. J. Physiol. 2008, 586:1791-1801.
82. Maljevic S., Wuttke T.V., Seebohm G., Lerche H. KV7 channelopathies. Pflugers Arch. 2010, 460:277-288.
83. Maljevic S., Naros G., Yalcin O., Blazevic D., Loeffler H., Caglayan H., Steinlein O.K., Lerche H. Temperature and pharmacological rescue of a folding-defective, dominant-negative KV 7.2 mutation associated with neonatal seizures. Hum. Mutat. 2011, 32:E2283-E2293.
84. Martire M., Castaldo P., D'Amico M., Preziosi P., Annunziato L., Taglialatela M. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J. Neurosci. 2004, 24:592-597.
85. Miceli F., Soldovieri M.V., Ambrosino P., Barrese V., Migliore M., Cilio M.R., Taglialatela M. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4386-4391.
86. Milh M., Boutry-Kryza N., Sutera-Sardo J., Mignot C., Auvin S., Lacoste C., Villeneuve N., Roubertie A., Heron B., Carneiro M., et al. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. Orphanet J. Rare Dis. 2013, 8:80.
87. Miraglia del Giudice E., Coppola G., Scuccimarra G., Cirillo G., Bellini G., Pascotto A. Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor. Eur. J. Hum. Genet. 2000, 8:994-997.
88. Misonou H., Trimmer J.S. Determinants of voltage-gated potassium channel surface expression and localization in Mammalian neurons. Crit. Rev. Biochem. Mol. Biol. 2004, 39:125-145.
89. Naegele J.R., Vemuri M.C., Studer L. Embryonic stem cell therapy for intractable epilepsy. Jasper's Basic Mechanisms of the Epilepsies 2012, U.S. National Center for Biotechnology Information, Bethesda, MD. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
90. Neubauer B.A., Waldegger S., Heinzinger J., Hahn A., Kurlemann G., Fiedler B., Eberhard F., Muhle H., Stephani U., Garkisch S., et al. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. Neurology 2008, 71:177-183.
91. Numis A.L., Angriman M., Sullivan J.E., Lewis A.J., Striano P., Nabbout R., Cilio M.R. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014, 82:368-370.
92. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Takeuchi T., Itohara S., Yanagawa Y., Obata K., et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 2007, 27:5903-5914.
93. Okada M., Zhu G., Hirose S., Ito K.I., Murakami T., Wakui M., Kaneko S. Age-dependent modulation of hippocampal excitability by KCNQ-channels. Epilepsy Res. 2003, 53:81-94.
94. Orhan G., Wuttke T.V., Nies A.T., Schwab M., Lerche H. Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data. Expert. Opin. Pharmacother. 2012, 13:1807-1816.
95. Orhan G., Bock M., Schepers D., Ilina E.I., Reichel S.N., Loffler H., Jezutkovic N., Weckhuysen S., Mandelstam S., Suls A., et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. Ann. Neurol. 2014, 75:382-394.
96. Otto J.F., Kimball M.M., Wilcox K.S. Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol. Pharmacol. 2002, 61:921-927.
97. Otto J.F., Singh N.A., Dahle E.J., Leppert M.F., Pappas C.M., Pruess T.H., Wilcox K.S., White H.S. Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions. Epilepsia 2009, 50:1752-1759.
98. Pan Z., Kao T., Horvath Z., Lemos J., Sul J.Y., Cranstoun S.D., Bennett V., Scherer S.S., Cooper E.C. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J. Neurosci. 2006, 26:2599-2613.
99. Paz J.T., Davidson T.J., Frechette E.S., Delord B., Parada I., Peng K., Deisseroth K., Huguenard J.R. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat. Neurosci. 2013, 16:64-70.
100. Peretz A., Degani N., Nachman R., Uziyel Y., Gibor G., Shabat D., Attali B. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol. Pharmacol. 2005, 67:1053-1066.
101. Peretz A., Pell L., Gofman Y., Haitin Y., Shamgar L., Patrich E., Kornilov P., Gourgy-Hacohen O., Ben-Tal N., Attali B. Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15637-15642.
102. Peters H.C., Hu H., Pongs O., Storm J.F., Isbrandt D. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat. Neurosci. 2005, 8:51-60.
103. Plant, L.D., Bayliss, D.A., Kim, D., Lesage, F., Goldstein, S.A.N., 2013. Two-P potassium channels. IUPHAR Database (IUPHAR-DB). Last modified on 06/12/2013. Accessed on 26/03/2014.
104. Porter R.J., Nohria V., Rundfeldt C. Retigabine. Neurotherapeutics 2007, 4:149-154.
105. Porter R.J., Partiot A., Sachdeo R., Nohria V., Alves W.M., Study G. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 2007, 68:1197-1204.
106. Rajakulendran S., Schorge S., Kullmann D.M., Hanna M.G. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics 2007, 4:258-266.
107. Rasband M.N. The axon initial segment and the maintenance of neuronal polarity. Nat. Rev. Neurosci. 2010, 11:552-562.
108. Rasmussen H.B., Frokjaer-Jensen C., Jensen C.S., Jensen H.S., Jorgensen N.K., Misonou H., Trimmer J.S., Olesen S.P., Schmitt N. Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment. J. Cell Sci. 2007, 120:953-963.
109. Regev N., Degani-Katzav N., Korngreen A., Etzioni A., Siloni S., Alaimo A., Chikvashvili D., Villarroel A., Attali B., Lotan I. Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity. PLoS One 2009, 4:e6586.
110. Reid C.A., Berkovic S.F., Petrou S. Mechanisms of human inherited epilepsies. Prog. Neurobiol. 2009, 87:41-57.
111. Rett A., Teubel R. Neugeborenen Krampfe im Rahmen einer epileptisch belasten Familie. Wien. Klin. Wochenschr. 1964, 76:609-613.
112. Richards M.C., Heron S.E., Spendlove H.E., Scheffer I.E., Grinton B., Berkovic S.F., Mulley J.C., Davy A. Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction. J. Med. Genet. 2004, 41:e35.
113. Robbins J., Passmore G.M., Abogadie F.C., Reilly J.M., Brown D.A. Effects of KCNQ2 gene truncation on M-type Kv7 potassium currents. PLoS One 2013, 8:e71809.
114. Roeloffs R., Wickenden A.D., Crean C., Werness S., McNaughton-Smith G., Stables J., McNamara J.O., Ghodadra N., Rigdon G.C. In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models. J. Pharmacol. Exp. Ther. 2008, 326:818-828.
115. Rundfeldt C., Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits. Neurosci. Lett. 2000, 282:73-76.
116. Saitsu H., Kato M., Koide A., Goto T., Fujita T., Nishiyama K., Tsurusaki Y., Doi H., Miyake N., Hayasaka K., et al. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Ann. Neurol. 2012, 72:298-300.
117. Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S., Atkinson D.L., Keating M.T. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996, 384:80-83.
118. Schenzer A., Friedrich T., Pusch M., Saftig P., Jentsch T.J., Grotzinger J., Schwake M. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J. Neurosci. 2005, 25:5051-5060.
119. Schmitt N., Schwarz M., Peretz A., Abitbol I., Attali B., Pongs O. A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J. 2000, 19:332-340.
120. Schmitt B., Wohlrab G., Sander T., Steinlein O.K., Hajnal B.L. Neonatal seizures with tonic clonic sequences and poor developmental outcome. Epilepsy Res. 2005, 65:161-168.
121. Schroeder B.C., Kubisch C., Stein V., Jentsch T.J. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 1998, 396:687-690.
122. Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C., Jentsch T.J. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J. Biol. Chem. 2000, 275:24089-24095.
123. Schwake M., Pusch M., Kharkovets T., Jentsch T.J. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy. J. Biol. Chem. 2000, 275:13343-13348.
124. Schwake M., Jentsch T.J., Friedrich T. A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. EMBO Rep. 2003, 4:76-81.
125. Schwake M., Athanasiadu D., Beimgraben C., Blanz J., Beck C., Jentsch T.J., Saftig P., Friedrich T. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly. J. Neurosci. 2006, 26:3757-3766.
126. Shieh C.C., Coghlan M., Sullivan J.P., Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 2000, 52:557-594.
127. Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J., Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V., et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 1998, 18:25-29.
128. Singh N.A., Westenskow P., Charlier C., Pappas C., Leslie J., Dillon J., Anderson V.E., Sanguinetti M.C., Leppert M.F. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003, 126:2726-2737.
129. Singh N.A., Otto J.F., Dahle E.J., Pappas C., Leslie J.D., Vilaythong A., Noebels J.L., White H.S., Wilcox K.S., Leppert M.F. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J. Physiol. 2008, 586:3405-3423.
130. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., Schwartzkroin P.A., Messing A., Tempel B.L. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819.
131. Smith J.S., Iannotti C.A., Dargis P., Christian E.P., Aiyar J. Differential expression of kcnq2 splice variants: implications to m current function during neuronal development. J. Neurosci. 2001, 21:1096-1103.
132. Soldovieri M.V., Castaldo P., Iodice L., Miceli F., Barrese V., Bellini G., Miraglia del Giudice E., Pascotto A., Bonatti S., Annunziato L., et al. Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions. J. Biol. Chem. 2006, 281:418-428.
133. Soldovieri M.V., Cilio M.R., Miceli F., Bellini G., Miraglia del Giudice E., Castaldo P., Hernandez C.C., Shapiro M.S., Pascotto A., Annunziato L., et al. Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. J. Neurosci. 2007, 27:4919-4928.
134. Soldovieri M.V., Boutry-Kryza N., Milh M., Doummar D., Heron B., Bourel E., Ambrosino P., Miceli F., De Maria M., Dorison N., et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A. Hum. Mutat. 2014, 35:356-367.
135. Steinlein O.K., Conrad C., Weidner B. Benign familial neonatal convulsions: always benign?. Epilepsy Res. 2007, 73:245-249.
136. Sugiura Y., Nakatsu F., Hiroyasu K., Ishii A., Hirose S., Okada M., Jibiki I., Ohno H., Kaneko S., Ugawa Y. Lack of potassium current in W309R mutant KCNQ3 channel causing benign familial neonatal convulsions (BFNC). Epilepsy Res. 2009, 84:82-85.
137. Tatulian L., Delmas P., Abogadie F.C., Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 2001, 21:5535-5545.
138. Tomlinson S.E., Rajakulendran S., Tan S.V., Graves T.D., Bamiou D.E., Labrum R.W., Burke D., Sue C.M., Giunti P., Schorge S., et al. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. J. Neurol. Neurosurg. Psychiatry 2013, 84:1107-1112.
139. Topsakal V., Pennings R.J., te Brinke H., Hamel B., Huygen P.L., Kremer H., Cremers C.W. Phenotype determination guides swift genotyping of a DFNA2/KCNQ4 family with a hot spot mutation (W276S). Otol. Neurotol. 2005, 26:52-58.
140. Tzingounis A.V., Nicoll R.A. Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19974-19979.
141. Uehara A., Nakamura Y., Shioya T., Hirose S., Yasukochi M., Uehara K. Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy. J. Membr. Biol. 2008, 222:55-63.
142. Vacher H., Mohapatra D.P., Trimmer J.S. Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol. Rev. 2008, 88:1407-1447.
143. Vallon V., Grahammer F., Richter K., Bleich M., Lang F., Barhanin J., Volkl H., Warth R. Role of KCNE1-dependent K+ fluxes in mouse proximal tubule. J. Am. Soc. Nephrol. 2001, 12:2003-2011.
144. Vigevano F., Fusco L., Di Capua M., Ricci S., Sebastianelli R., Lucchini P. Benign infantile familial convulsions. Eur. J. Pediatr. 1992, 151:608-612.
145. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., VanRaay T.J., Shen J., Timothy K.W., Vincent G.M., de Jager T., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 1996, 12:17-23.
146. Wang H.S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S., Dixon J.E., McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998, 282:1890-1893.
147. Warth R., Barhanin J. The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R639-R648.
148. Watanabe H., Nagata E., Kosakai A., Nakamura M., Yokoyama M., Tanaka K., Sasai H. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J. Neurochem. 2000, 75:28-33.
149. Weber Y.G., Geiger J., Kampchen K., Landwehrmeyer B., Sommer C., Lerche H. Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain. Brain Res. 2006, 1077:1-6.
150. Weckhuysen S., Mandelstam S., Suls A., Audenaert D., Deconinck T., Claes L.R., Deprez L., Smets K., Hristova D., Yordanova I., et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann. Neurol. 2012, 71:15-25.
151. Weckhuysen S., Ivanovic V., Hendrickx R., Van Coster R., Hjalgrim H., Moller R.S., Gronborg S., Schoonjans A.S., Ceulemans B., Heavin S.B., et al. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. Neurology 2013, 81:1697-1703.
152. Wehling C., Beimgraben C., Gelhaus C., Friedrich T., Saftig P., Grotzinger J., Schwake M. Self-assembly of the isolated KCNQ2 subunit interaction domain. FEBS Lett. 2007, 581:1594-1598.
153. Wei A.D., Gutman G.A., Aldrich R., Chandy K.G., Grissmer S., Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol. Rev. 2005, 57:463-472.
154. Wickenden A.D., Krajewski J.L., London B., Wagoner P.K., Wilson W.A., Clark S., Roeloffs R., McNaughton-Smith G., Rigdon G.C. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol. Pharmacol. 2008, 73:977-986.
155. Wulff H., Castle N.A., Pardo L.A. Voltage-gated potassium channels as therapeutic targets. Nat. Rev. Drug Discov. 2009, 8:982-1001.
156. Wuttke T.V., Lerche H. Novel anticonvulsant drugs targeting voltage-dependent ion channels. Expert Opin. Investig. Drugs 2006, 15:1167-1177.
157. Wuttke T.V., Seebohm G., Bail S., Maljevic S., Lerche H. The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol. Pharmacol. 2005, 67:1009-1017.
158. Wuttke T.V., Jurkat-Rott K., Paulus W., Garncarek M., Lehmann-Horn F., Lerche H. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology 2007, 69:2045-2053.
159. Wuttke T.V., Penzien J., Fauler M., Seebohm G., Lehmann-Horn F., Lerche H., Jurkat-Rott K. Neutralization of a negative charge in the S1-S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy. J. Physiol. 2008, 586:545-555.
160. Wykes R.C., Heeroma J.H., Mantoan L., Zheng K., MacDonald D.C., Deisseroth K., Hashemi K.S., Walker M.C., Schorge S., Kullmann D.M. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl. Med. 2012, 4:161ra152.
161. Yang W.P., Levesque P.C., Little W.A., Conder M.L., Ramakrishnan P., Neubauer M.G., Blanar M.A. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J. Biol. Chem. 1998, 273:19419-19423.
162. Yus-Najera E., Santana-Castro I., Villarroel A. The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels. J. Biol. Chem. 2002, 277:28545-28553.
163. Zara F., Specchio N., Striano P., Robbiano A., Gennaro E., Paravidino R., Vanni N., Beccaria F., Capovilla G., Bianchi A., et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia 2013, 54:425-436.